Last updated: 2026-09-16 06:19:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Adial Pharmaceuticals, Inc. (ADIL) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $5.06, with a market capitalization of $14.67M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.31 to $10.75. This page covers its latest market performance, valuation, price trends and company information.
$14.67M | |
$5.02 | |
$5,900.00 | |
$1.31 | |
$5.00 | |
24.54K | |
76.43K | |
-- | |
$10.75 | |
$1.31 | |
-- | |
-- |
Adial Pharmaceuticals, Inc. (ADIL) last closed at $5.00 as of 2026-09-15 23:31:00, unchanged from the previous close of $5.00.
During the latest regular trading session, ADIL traded between $1.31 and $5,900.00, with a volume of 24.54K shares. The closing price was near the lower end and near the middle of its 52-week range.
Over the past seven days, Adial Pharmaceuticals, Inc. (ADIL) moved from $6.66 to $5.06, representing a decline of 23.96% ($1.60).
The stock traded between $4.80 and $7.20 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 55.94 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 39.8%
ADIL is currently trading at $5.06, placing it 39.8% of the way from its 52-week low of $1.31 to its 52-week high of $10.75. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 6 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Adial Pharmaceuticals, Inc. (ADIL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.